Bifosfonat Kullanımına Bağlı Gelişen Mandibula ve Maksilla Nekrozları ve Dental Yaklaşım

Dental ve tıbbi literatürde yeni bir antiteolarak tanımlanan bifosfonatlara bağlıolarak geliflen çene osteonekrozları, hergeçen gün artan rapor edilmifl vakalarlabirlikte günümüzde literatürde çok önemlibir yer tutar hale gelmifltir. Literatür incelendiğinde bifosfonat kullanımına bağlıgeliflen çene osteonekrozlarının geliflimi,teflhisi, tedavisi ve korunma yollarıhakkında pek çok makalenin yer aldığıancak henüz arafltırılması gereken pek çoknoktanın mevcut olduğu görülmektedir. Buderlemede bifosfonatlara bağlı olarakgeliflen çene osteonekrozları ve konu ileilgili difl hekimliği yaklaflımları ele alınarakdeğerlendirilmifl ve tartıflılmıfltır

Anahtar Kelimeler:

Bifosfonat, Mandibula Nekrozu, Maksilla Nekrozu, Dental yaklaşım

Bisphosphonat-Related Jaw Necrosis and Dental Management

Bisphosphonate-related which is a new entity in dental and medicalliterature, has become to an important partof the literature with a growing number ofreported cases. When we search the literature for bisphosphonate-related jaw necrosis we can find a lot of reports about itspathology, diagnosis, management andprevention but there are many more subjects to search are found. In this review,bisphosphonat-related jaw necrosis anddental management of this subject is evaluated and discussed

Keywords:

Bisfosfonat, Jaw Necrosis, Dental Management,

PDF

___

Coleman RE: Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27: 165, 2001 11. Hellstein JW, Marek CL: Bisphosphonate osteochemonecrosis (Bis-phossy jaw): Is this Phossy jaw of the 21st century?. J Oral Maxillofac Surg 63:682-689, 2005
Marx RE: Pamidronate (Aredia) and zoldronate (Zometa) induced avascular necrosis of the jaws: a growing epidem- ic. J Oral Maxillofac Surg 61:1115-, 2003
Badros A, Weikel d, Salama A, Goloubeva O, Schneider a, Rapoport A, Fenton R, Gahres N, Sausville E, Ord R, Meiller T. Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical features and Risk Factors. J Clin Oncol 24:945-952, 2006
Bamias A, Kastritis E, Bamia C, Moulopoulo L, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnotopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA. Osteonecrosis of the Jaw in cancer after treatment with Bisphosphonates: Incidence and Risk Factors. J Clin Oncol 23:8580-8587, 2006
Marx RE, Sawatari Y, Fortin M, Broumand V: Bisphosphonate-induced (Osteonecrosis/Osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567-1575, 2005 exposed bone
Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O: Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 117:440-1, 2004
Migliorati CA, Bisphosphonates and oral cavity avascular bone necrosis J Clin Oncol 21: 4253, 2003
Zarychanski R, Elphee E, Walton P, Johnston J: Osteonecrosis of the jaw associated with pamidronate therapy.
Am J Hematol 81(1):73-5, 2006
Carter GD, Gross AN: Bisphosphonates and avascular necrosis of the jaw. Aust Dent J 48:268, 2003
Schuster MW, Dymek JM: Oral cavity avascular bone necrosis: a newly recognized complication of intravenous (IV) bisphosphonate therapy in cancer patients (abstract 4905). Blood 104(11), 2004
Lin JH, Russell G, Gertz B: Pharmacokinetics of alen- dronate: an overview. Int J Clin Pract Suppl 101:18-26, 1999
Pogrel MA: Bisphosphonates and bone necrosis. J Oral Maxillofac Surg 62:391-2, 2004
Wooltorton E: Patients receiving intravenous bisphospho- nates should avoid invase dental procedures. CMAJ June 1, 2005
Sarathy AP, Bourgeois Jr SL, Goodell GG: Bisphosphonate-associated osteonecrosis of the jaw and endodontic treatment: two case reports. J Endod 31(10):759-63, 2005
Hwang D, Wang HL. Medical contraindications to implant therapy: part I: absolute contraindications. Implant Dent. 2006 Dec;15(4):353-60
Scully C,Madrid C, Bagan J Dental endosseous implants in patients onbisphosphonate therapy. Implant Dent. 2006 Sep;15(3):212-8.
Melo MD, Obeid G. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strate- gies for prevention and early recognition. J Am Dent Assoc. 2005 Dec;136(12):1675-81.